Target Audience This activity is designed to meet the educational needs of physicians, nurses, and advanced practice clinicians who manage patients with multiple sclerosis (MS). Program Description In MS management, the concepts of NEDA for “no evidence of disease activity” and MEDA for “minimal evidence of disease activity” have emerged in an attempt to define …
Continue reading “NEDA or MEDA? Defining Treatment Goals in Multiple Sclerosis”
Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives 1) Describe new approaches to optimize adherence through shared decision-making and patient engagement principles. 2) Integrate shared decision-making principles and models into clinical practice. Accreditation …
Continue reading “IJMSC: Impact of Shared Decision Making on Disease-Modifying Drug Adherence in MS”
Nurse practitioners in primary care settings are on the first line to recognize motor, sensory, and cognitive deficits that may help establish a diagnosis of MS. While referral to a neurologist is often made, patients with chronic illnesses such as MS often return to the primary care setting for management. In their multi-faceted roles of …
Continue reading “NP Connections: The Role of the Nurse Practitioner in Multiple Sclerosis Care”
For many patients with MS, current disease-modifying therapies (DMTs) can provide control of disease activity especially when more aggressive treatment is initiated early in the disease course. The CE-certified supplement, Risk-Benefit Analysis and Personalized Treatment in Multiple Sclerosis: Basing Treatment Goals on the Latest Evidence, provides clinicians with the most up-to-date evidence on current and …
Continue reading “Risk-Benefit Analysis and Personalized Treatment in MS”
Release Date: 6/30/2020 Expiration Date: 6/29/2021 The third edition of the Advances in Multiple Sclerosis Primer provides an educational experience featuring interactive cases and expert faculty commentary on a variety of MS topics. The content contains many recent updates to the second edition, as well as new sections including diagnosis and continuity of care. Click …
Continue reading “Advances in Multiple Sclerosis (AIMS) Primer: Third Edition”
May 16, 2018 from 8:00 pm to 9:00 pm Writing for scientific publication and presentation in MS nursing is essential to disseminate evidence, share innovations with others, provide new information to keep nurses updated, and share finding of outcomes data collection and research studies. Writing is hard work but the process can be simplified by …
Continue reading “Writing for Publication in Multiple Sclerosis: Webinar PART 2”
Release date: February 15, 2018Valid through: February 15, 2020 Earn 1.5 continuing education credits! Description Comorbidity is an area of increasing interest in MS and evidence has suggested comorbidity is associated with diagnostic delays, misinterpretation of relapses, disability progression, health-related quality of life, and progression of lesion burden on magnetic resonance imaging (MRI). In chronic diseases, it …
Continue reading “Comorbidities in Multiple Sclerosis: A Clinical Resource Guide”
Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives 1) Apply new information about MS to a comprehensive individualized treatment plan for patients with MS 2) Integrate the team approach into long-term planning in …
Activity Description and Learning Objectives In this case-based activity, experts in the diagnosis and management of multiple sclerosis discuss practical issues related to personalizing care in patients with this disease. Upon completion of this activity, participants will be able to: Employ updated MS phenotype descriptions and other patient-and disease-specific factors when personalizing treatment regimens in …